DHEA replacement after menopause: HRT 2000 or nostrum of the '90s?

Contemporary Ob-Gyn

Volumn 42, Issue 4, 1997, Pages 119-133

  Casson, Peter R ^a   Buster, John E ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0347076293     PISSN: 00903159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Yen SSC: Chronic anovulation caused by peripheral endocrine disorders, in Yen SSC, Jaffe RB, (eds): Reproductive Endocrinology. 3rd ed. Philadelphia, Pa., W.B. Saunders, 1891, pp 576-630
2. Endoh A, Kristiansen SB, Casson PR, et al: The zona reticularis is the site of biosynthesis of dehydroepiandrosterone and dehydroepiandrosterone sulfate in the adult human adrenal cortex, resulting from its low expression of 3β-hydroxysteroid dehydrogenase. J Clin Endocrinol Metab 1996 (in press)
3. Casson PR, Straughn AB, Umstot ES, et al: Delivery of dehydroepiandrosterone (DHEA) to premenopausal women: Effects of micronization and non-oral administration. Am J Obstet Gynecol 1995;174:649
4. Orentreich N, Brind JL, Rizer RL, et al: Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 1984;59:551
5. Coleman OL, Leiter EH, Schwizer RW: Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice. Diabetes 1982;31:830
6. VY/A mice by dehydroepiandrosterone. Lipids 1977;12:409
7. Schwartz AG, Pashko LL: Cancer chemoprevention with the adrenocortical steroid dehydroepiandrosterone and structural analogs. J Cell Biochem 1993;17G:73
8. Melchior CL, Ritzmann RF: Dehydroepiandrosterone is an anxiolytic in mice on the plus maze. Pharmacol Biochem Behav 1994;47:437
9. Roberts E: Dehydroepiandrosterone (DHEA) and its sulfate (DHEAS) as neural facilitators: Effects on brain tissue in culture and on memory in young and old mice. A cyclic GMP hypothesis of action of DHEA and DHEAS in nervous system and other tissues, in Kalimi M, Regelson W, (eds): The Biologic Role of Dehydroepiandrosterone (DHEA). Berlin, Walter de Gruyter, 1990, p 1342
10. Eich DM, Nestler JE, Johnson DE, et al: Inhibition of accelerated coronary atherosclerosis with dehydroepiandrosterone in the heterotopic rabbit model of cardiac transplantation. Circulation 1993;87:261
11. Daynes RA, Dudley DJ, Araneo BA: Regulation of murine lymphokine production in vivo: Dehydroepiandrosterone is a natural enhancer of interleukin 2 synthesis by helper T cells. Eur J Immunol 1990;20:793
12. Imai A, Ohno T, Tamaya T: Dehydroepiandrosterone sulfate-binding sites in plasma membrane from human uterine cervical fibroblasts. Experientia 1992;48:999
13. Meikie AW, Dorchuck RW, Araneo BA, et al: The presence of dehydroepiandrosterone-specific receptor binding complex in murine t cells. J Steroid Biochem Molec Biol 1992;42:293
14. Kalimi M, Shafogoi Y, Loria R, et al: Antiglucocorticoid effects of dehydroepiandrosterone (DHEA). Molec Cell Biochem 1994;131:99
15. Ebeling P, Koivisto VA: Physiological importance of dehydroepiandrosterone. Lancet 1994;343:1479
16. Labrie F, Belanger A, Simard J, et al: DHEA and peripheral androgen and estrogen formation: Intracrinology, in Bellino FL, Daynes RA, Hornsby PJ, et al (eds): Dehydroepiandrosterone (DHEA) and Aging. 774th ed. New York, NY, Acad Science, 1996 pp 16-28
17. Barrett-Connor E, Khaw KT, Yen SSC: A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med 1986;315:1519
18. Barrett-Connor E, Goodman-Gruen D: Dehydroepiandrosterone sulfate does not predict cardiovascular death in postmenopausal women. Circulation 1995;91:1757
19. Barrett-Connor E, Goodman-Gruen D: The epidemiology of DHEAS and cardiovascular disease, in Bellino FL, Daynes RA, Hornsby PJ, et al (eds): Dehydroepiandrosterone (DHEA) and Aging. 774th ed. New York, NY Academy of Science, 1995, pp 259-270
20. Zumoff B, Levin J, Rosenfeld RS, et al: Abnormal 24-hr mean plasma concentrations of dehydroisoandrosterone and dehydroepiandrosterone sulfate in women with primary operable breast cancer. Cancer Res 1981;41:3360
21. Berkman LF, Seeman TE, Albert M, et al: High, usual and impaired functioning in community-dwelling older men and women: Findings from the MacArthur foundation research network on successful aging. J Clin Epidemiol 1993;46:1129
22. Nestler JE, Barlascini CO, Clore JN, et al: Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J Clin Endocrinol Metab 1988;66:5741
23. Welle S, Jozefowicz R, Statt M: Failure of DHEA to influence energy and protein metabolism in humans. J Clin Endocrinol Metab 1990;71:1259
24. Usiskin KS, Butterworth S, Clore JN, et al: Lack of effect of dehydroepiandrosterone in obese men. Int J Obes 1990;14:457
25. Zumoff B, Strain GW, Heymsfield SB, et al: A randomized double-blind crossover study of the antiobesity effects of etiocholanedione. Obes Res 1994;2:13
26. Mortola J, Yen SSC: The effects of dehydroepiandrosterone on endocrine-metabolic parameters in post-menopausal women. J Clin Endocrinol Metab 1990;71:696
27. Buster JE, Casson PR, Straughn AB, et al: Postmenopausal steroid replacement with micronized dehydroepiandrosterone: Preliminary oral bioavailability and dose proportionality studies. Am J Obstet Gynecol 1992;166:1163
28. Casson PR, Andersen RN, Herrod HG, et al: Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal women. Am J Obstet Gynecol 1993;169:1536
29. Casson PR, Faquin LC, Stentz FB, et al: Replacement of dehydroepiandrosterone enhances T-lymphocyte insulin binding in postmenopausal women. Fertil Steril 1995;63:1027
30. Bates, Jr. GW, Egerman RS, Umstot ES, Buster JE, Casson PR: Dehydroepiandrosterone attenuates study-induced declines in insulin sensitivity in postmenopausal women in Bellino FL, Daynes RA, Hornsby PJ, et al (eds): Dehydroepiandrosterone (DHEA) and aging. 774th ed. New York, NY Academy of Science, 1995, pp 291-293
31. Morales AJ, Nolan JJ, Nelson JC, et al: Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 1994;78:1360
32. Rudman D, Feller AG, Nagraj HS, et al: Effects of human growth hormone in men over 60 years old. N Engl J Med 1990;323:52
33. Duerr RL, Huang S, Miraliakbar HR, et al: Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. J Clin Invest 1995;95:619
34. Yen SCC, Morales AJ, Khorram O: Replacement of DHEA in again men and women: Potential remedial effects in Bellino FL, Daynes RA, Homsby PJ, et al (eds): Dehydroepiandrosterone (DHEA) and Aging. 774th ed. New York, NY Academy of Science, 1995, pp 28-142
35. Friess E, Trachsel L, Guldner J, et al: DHEA administration increases rapid eye movement sleep and EEG power in the sigma frequency range. Am J Physiol 1995;268:E107
36. Araneo BA, Doweli T, Woods MA, et al: DHEA as an effective vaccine adjuvant in elderly humans in Bellino FL, Daynes RA, Hornsby PJ, et al (eds): Dehydroepiandrosterone (DHEA) and Aging. 774th ed. New York, NY Academy of Science, 1995, pp 232-248
37. DynerTS, Lang W, Geaga J, et al: An open-label dose-escalation trial of oral dehydroepiandrosterone tolerance and pharmacokinetics in patients with HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol 1993;6:459
38. van Vollenhoven RF, Englemen EG, McGuire JL: An open study of dehydroepiandrosterone in systemic lupus erythematosus. Arthr Rheum 1994;37:1305
39. Westaby D, Paradinas FJ, Ogle SJ, et al: Liver damage from long-term methyltestosterone. Lancet 1977;8:261
40. Rao MS, Subbarao V, Yeldandi AV, et al: Hepatocarcinogenicity of dehydroepiandrosterone in the rat. Cancer Res 1992;52:3977